Is the treatment of CIN 2 always necessary in women under 25 years old?
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 21872201.
- Also identified by DOI 10.1016/j.ajog.2011.06.069.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to review the outcome of conservatively managed cervical intraepithelial neoplasia (CIN) 2 in women <25 years old. This was a retrospective review that included women who were <25 years old with biopsy proven CIN2 between 2005 and 2009. Analysis was performed that compared women who had immediate treatment with women whose treatment was deferred >4 months. The primary outcome measure was spontaneous regression of CIN2. Secondary outcomes were treatment rates and loss to follow-up evaluation. Of the 452 women who were identified, 256 women (57%) received immediate treatment; 157 women (35%) met the definition for conservative management, and 39 women (9%) had unknown subsequent management. Of the 157 women who were managed conservatively, 98 women (62%) showed spontaneous regression, with a median of 8 months observation. No conservatively managed women progressed to cancer. Based on the 62% regression rate in this study, routine treatment may not be necessary for all women with CIN2 who are <25 years old.
Medical subject headings
- Uterine Cervical Dysplasia
- Uterine Cervical Neoplasms